CIPO trademark

ZEGFROVY

FiledCIPOFigurative markClass 5

"ZEGFROVY" is a figurative mark owned by AstraZeneca UK Limited, filed at the CIPO on April 2, 2026. It is filed and waiting for examination and covers class 5 (Pharmaceuticals).

View AstraZeneca UK Limited portfolioGet this data via the API
Official CIPO record
ZEGFROVY trademark as filed
As filed with the CIPO
Status
Filed
Since April 2, 2026
Filed
April 2, 2026
Registered
Not yet
Expires
Not recorded
Application no.
2467017
Registration no.
Not yet
Office
CIPO
Canadian Intellectual Property Office
Mark type
Figurative mark
1 class
Ownership

Who owns ZEGFROVY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

AstraZeneca UK Limited

United Kingdom

1,763 trademarks in the portfolioView company

Representative

Lei Zhou

Lei Zhou

Goods and services

What the mark covers

The products and services ZEGFROVY is filed for, grouped by Nice class.

  • Anti-cancer preparations; antitumor drugs; antivirals; biological preparations made from human blood cells for cell therapy; biopharmaceuticals for the treatment of cancer; chemotherapeutics; diagnostic chemical reagents for medical purposes; drug delivery agents in the form of dissolvable tablets that provide rapid release of the active ingredients for a wide variety of pharmaceuticals; excipients for use in pharmaceuticals to treat cancer; human pharmaceuticals for treatment of cancer; injectable preparations made of solutions of hyaluronic acid for medical and pharmaceutical purposes; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for the treatment of interstitial lung disease (ILD); pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for use in chemotherapy; pharmaceutical products for the treatment of cancer; tumor suppressing agents

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Change of Title Registered; Assignment/Cession
  2. FROM/DE: Dizal Pharmaceutical Co., Ltd.; TO/A: AstraZeneca UK Limited
  3. Formalized
  4. Created
  5. Filed
FAQ

About ZEGFROVY

Who owns the trademark "ZEGFROVY"?

The CIPO trademark "ZEGFROVY" (application 2467017) is owned by AstraZeneca UK Limited.

What is the status of "ZEGFROVY"?

Its status at the CIPO is: filed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ZEGFROVY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019def9b-10e8-7545-9ae1-a16b23428bf0
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019def9b-10e8-7545-9ae1-a16b23428bf0",
  "object": "trademark",
  "mark_text": "ZEGFROVY",
  "status": {
    "primary": "pending",
    "stage": "filed"
  },
  "office_code": "CA",
  "application_number": "2467017",
  "filing_date": "2026-04-02",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "AstraZeneca UK Limited",
      "entity_id": "ent_019eb6f8-0fa0-77ee-aa49-b354fdb26532"
    }
  ]
}